Guaifenesin and Developmental delay - a phase IV clinical study of FDA data

Summary:

Developmental delay is reported as a side effect among people who take Guaifenesin (guaifenesin), especially for people who are male, 0-1 old, have been taking the drug for 1 - 2 years also take Amoxicillin, and have Mood swings.

The phase IV clinical study analyzes which people have Developmental delay when taking Guaifenesin. It is created by eHealthMe based on reports of 11,942 people who have side effects when taking Guaifenesin from the FDA, and is updated regularly.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.

What is Developmental delay?

Developmental delay is found to be associated with 361 drugs and 428 conditions by eHealthMe. Check the latest studies of Developmental delay.

On Jul, 14, 2026

11,942 people reported to have side effects when taking Guaifenesin.
Among them, 28 people (0.23%) have Developmental delay.

Could Guaifenesin cause Developmental delay?

Among these 28 people:

How long have people been on Guaifenesin when they have Developmental delay? *

What is the gender of people who have Developmental delay when taking Guaifenesin? *

female: 0.0 %
male: 100 %

What is the age of people who have Developmental delay when taking Guaifenesin? *

What are other drugs people take besides Guaifenesin? *

What are other side effects people have besides Developmental delay? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 9 people, 32.14%
Speech Disorder Developmental: 9 people, 32.14%
Acute Kidney Failure: 8 people, 28.57%
Respiratory Distress (difficulty in breathing): 8 people, 28.57%
Tracheitis (an inflammation of the trachea): 8 people, 28.57%
Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 8 people, 28.57%
Pulmonary Artery Stenosis Congenital (congenital -narrowing (stenosis) that occurs in the lung artery): 8 people, 28.57%
Tachypnea: 8 people, 28.57%
Coarctation Of The Aorta (narrowing of the part of aorta): 8 people, 28.57%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 28.57%

What are the existing conditions these people have? *

Depression: 8 people, 28.57%
Mood Swings (an extreme or rapid change in mood): 8 people, 28.57%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 25.00%
Influenza Like Illness: 7 people, 25.00%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 4 people, 14.29%
Back Pain: 3 people, 10.71%
Pain: 3 people, 10.71%
Infection: 3 people, 10.71%
High Blood Cholesterol: 2 people, 7.14%
Abdominal Pain: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Guaifenesin and have Developmental delay?

- Check whether Developmental delay is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Guaifenesin:

Guaifenesin (12,106 reports)

Browse all side effects of Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Developmental delay:

Developmental delay (361 drugs)

Browse all the conditions that are associated with Developmental delay:

Developmental delay (428 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin (the active ingredients of Guaifenesin) and Guaifenesin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.